Dilemmas in the diagnosis and pathogenesis of atypical late‐onset familial haemophagocytic lymphohistiocytosis

por Minson, Adrian, Voskoboinik, Ilia, Grigg, Andrew
Publicado 2021

Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma

por Cliff, Edward R. Scheffer, Reynolds, Gemma, Grigg, Andrew
Publicado 2023

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission

por Hawkes, Eliza A, Loh, Zoe, Estacio, Ortis, Chong, Geoff, Ha, Francis J, Gilbertson, Michael, Grigg, Andrew
Publicado 2018

Ferrihydrite transformations in flooded paddy soils: rates, pathways, and product spatial distributions

por Grigg, Andrew R. C., ThomasArrigo, Laurel K., Schulz, Katrin, Rothwell, Katherine A., Kaegi, Ralf, Kretzschmar, Ruben
Publicado 2022

Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia

por van Zelm, Menno C., Pumar, Marsus, Shuttleworth, Peter, Aui, Pei M., Smart, Joanne M., Grigg, Andrew, Bosco, Julian J.
Publicado 2019

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

por Grigg, Andrew, Dyer, Martin J.S., Díaz, Marcos González, Dreyling, Martin, Rule, Simon, Lei, Guiyuan, Knapp, Andrea, Wassner-Fritsch, Elisabeth, Marlton, Paula
Publicado 2017

A New Approach for Investigating Iron Mineral Transformations in Soils and Sediments Using (57)Fe-Labeled Minerals and (57)Fe Mössbauer Spectroscopy

por Notini, Luiza, Schulz, Katrin, Kubeneck, L. Joëlle, Grigg, Andrew R. C., Rothwell, Katherine A., Fantappiè, Giulia, ThomasArrigo, Laurel K., Kretzschmar, Ruben
Publicado 2023

Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment f...

por Mir, Farheen, Mattiello, Federico, Grigg, Andrew, Herold, Michael, Hiddemann, Wolfgang, Marcus, Robert, Seymour, John F., Bolen, Christopher R., Knapp, Andrea, Nielsen, Tina, Casulo, Carla
Publicado 2020

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study

por Moreno, Carol, Solman, Isabelle G., Tam, Constantine S., Grigg, Andrew, Scarfò, Lydia, Kipps, Thomas J., Srinivasan, Srimathi, Mali, Raghuveer Singh, Zhou, Cathy, Dean, James P., Szafer-Glusman, Edith, Choi, Michael
Publicado 2023

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

por Seymour, John F., Marcus, Robert, Davies, Andrew, Gallop-Evans, Eve, Grigg, Andrew, Haynes, Andrew, Herold, Michael, Illmer, Thomas, Nilsson-Ehle, Herman, Sökler, Martin, Dünzinger, Ulrich, Nielsen, Tina, Launonen, Aino, Hiddemann, Wolfgang
Publicado 2019

A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML

por Schwarer, Anthony P., Butler, Jason, Jackson, Kathryn, Beligaswatte, Ashanka, Martin, Louisa, Kennedy, Glen, Daniela, Zantomio, Lewis, Ian, Hiwase, Devendra, Wight, Joel, He, Simon, Grigg, Andrew, Morris, Kirk, Mollee, Peter, Marlton, Paula
Publicado 2018

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma

por Nath, Christa Ellen, Grigg, Andrew, Rosser, Sebastian P. A., Estell, Jane, Newman, Elizabeth, Tiley, Campbell, Ramanathan, Sundra, Ho, Shir Jing, Larsen, Stephen, Gibson, John, Presgrave, Peter, Shaw, Peter John, Trotman, Judith
Publicado 2022

Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing

por Lopez, Jamie A., Noori, Tahereh, Minson, Adrian, Li Jovanoska, Lu, Thia, Kevin, Hildebrand, Michael S., Akhlaghi, Hedieh, Darcy, Phillip K., Kershaw, Michael H., Brown, Natasha J., Grigg, Andrew, Trapani, Joseph A., Voskoboinik, Ilia
Publicado 2018

P668: CHRONIC MYELOID LEUKEMIA SURVEY ON UNMET NEEDS (CML SUN): BALANCING TOLERABILITY AND EFFICACY GOALS OF PATIENTS AND PHYSICIANS THROUGH SHARED TREATMENT DECISION-MAKING

por Lang, Fabian, Pemberton-Whiteley, Zack, Clements, Joannie, Ruiz, Cristina, Rea, Delphine, Machado, Lisa, Takahashi, Naoto, Moon, Sung-Ho, P Grigg, Andrew, Borowczak, Cornelia, Schuld, Peter, Frank, Pauline, Constantinescu, Cristina, Boquimpani, Carla, Cortes, Jorge
Publicado 2023

Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts

por Barr, Paul M., Tedeschi, Alessandra, Wierda, William G., Allan, John N., Ghia, Paolo, Vallisa, Daniele, Jacobs, Ryan, O'Brien, Susan, Grigg, Andrew P., Walker, Patricia, Zhou, Cathy, Ninomoto, Joi, Krigsfeld, Gabriel, Tam, Constantine S.
Publicado 2022

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia

por Tiong, Ing S., Dillon, Richard, Ivey, Adam, Teh, Tse‐Chieh, Nguyen, Phillip, Cummings, Nicholas, Taussig, David C., Latif, Annie‐Louise, Potter, Nicola E., Runglall, Manohursingh, Russell, Nigel H., Raj, Kavita, Schwarer, Anthony P., Fong, Chun Yew, Grigg, Andrew P., Wei, Andrew H.
Publicado 2020

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

por Townsend, William, Hiddemann, Wolfgang, Buske, Christian, Cartron, Guillaume, Cunningham, David, Dyer, Martin J.S., Gribben, John G., Phillips, Elizabeth H., Dreyling, Martin, Seymour, John F., Grigg, Andrew, Trotman, Judith, Lin, Tong-Yu, Hong, Xiao-Nan, Kingbiel, Dirk, Nielsen, Tina G., Knapp, Andrea, Herold, Michael, Marcus, Robert
Publicado 2023

Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

por Evens, Andrew M., Connors, Joseph M., Younes, Anas, Ansell, Stephen M., Kim, Won Seog, Radford, John, Feldman, Tatyana, Tuscano, Joseph, Savage, Kerry J., Oki, Yasuhiro, Grigg, Andrew, Pocock, Christopher, Dlugosz-Danecka, Monika, Fenton, Keenan, Forero-Torres, Andres, Liu, Rachael, Jolin, Hina, Gautam, Ashish, Gallamini, Andrea
Publicado 2021

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention

por Shanmuganathan, Naranie, Wadham, Carol, Shahrin, NurHezrin, Feng, Jinghua, Thomson, Daniel, Wang, Paul, Saunders, Verity, Kok, Chung Hoow, King, Rob M., Kenyon, Rosalie R., Lin, Ming, Pagani, Ilaria S., Ross, David M., Yong, Agnes S.M., Grigg, Andrew P., Mills, Anthony K., Schwarer, Anthony P., Braley, Jodi, Altamura, Haley, Yeung, David T., Scott, Hamish S., Schreiber, Andreas W., Hughes, Timothy P., Branford, Susan
Publicado 2023

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

por Stadtmauer, Edward A., Sullivan, Keith M., El Idrissi, Mohamed, Salaun, Bruno, Alonso Alonso, Aránzazu, Andreadis, Charalambos, Anttila, Veli-Jukka, Bloor, Adrian JC, Broady, Raewyn, Cellini, Claudia, Cuneo, Antonio, Dagnew, Alemnew F., Di Paolo, Emmanuel, Eom, HyeonSeok, González-Rodríguez, Ana Pilar, Grigg, Andrew, Guenther, Andreas, Heineman, Thomas C., Jarque, Isidro, Kwak, Jae-Yong, Lucchesi, Alessandro, Oostvogels, Lidia, Polo Zarzuela, Marta, Schuind, Anne E., Shea, Thomas C., Sinisalo, Ulla Marjatta, Vural, Filiz, Yáñez San Segundo, Lucrecia, Zachée, Pierre, Bastidas, Adriana
Publicado 2021